Panacea Biotec terminates MoU with Refana for COVID-19 vaccine
The company informed that the termination is due to delays in project timelines and difficulty in moving ahead with the joint…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Refana
Panacea Biotec aims to make 1-bn doses of COVID-19 vaccine candidate in 2022
The company said last month it would partner with US-based Refana Inc to make a potential COVID-19 vaccine, in a collaboration…
Panacea Biotec and Refana announce landmark collaboration for COVID-19 vaccine
Collaboration will enable global development, manufacturing and distribution of the Candidate COVID-19 vaccine